Dry eye: diagnosis and current treatment strategies
- PMID: 15175147
- DOI: 10.1007/s11882-004-0077-2
Dry eye: diagnosis and current treatment strategies
Abstract
One in four patients attending ophthalmic clinics report symptoms of dry eye, making it one of the most common complaints seen by ophthalmologists. Aqueous-layer deficiency is the most common form of dry eye and is frequently caused by decreased secretion of tears by the lacrimal glands. Evaporative dry eye is often secondary to meibomian gland disease and results in a defective lipid layer. Tear replacement or preservation using artificial tears and/or punctal occlusion are the mainstay of treatment. Newer forms of therapy were designed to modify the underlying disease process. These include the use of topical cyclosporin A, autologous serum, and sodium hyaluronate drops, which suppress underlying inflammation, provide growth factors, and prevent the onset of squamous metaplasia in ocular surface epithelium. Hormonal therapy might have a role in the future of dry eye therapy.
Similar articles
-
LASIK and dry eye.Compr Ophthalmol Update. 2007 Mar-Apr;8(2):79-85; discussion 87-9. Compr Ophthalmol Update. 2007. PMID: 17540125 Review.
-
Dry eye in the elderly.Drugs Aging. 2001;18(2):101-7. doi: 10.2165/00002512-200118020-00003. Drugs Aging. 2001. PMID: 11346124 Review.
-
[A new approach for better comprehension of diseases of the ocular surface].J Fr Ophtalmol. 2007 Mar;30(3):239-46. doi: 10.1016/s0181-5512(07)89584-2. J Fr Ophtalmol. 2007. PMID: 17417148 French.
-
The diagnosis and management of dry eye: a twenty-five-year review.Cornea. 2000 Sep;19(5):644-9. doi: 10.1097/00003226-200009000-00009. Cornea. 2000. PMID: 11009316 Review.
-
Punctal occlusion for dry eye syndrome.Cochrane Database Syst Rev. 2017 Jun 26;6(6):CD006775. doi: 10.1002/14651858.CD006775.pub3. Cochrane Database Syst Rev. 2017. PMID: 28649802 Free PMC article. Review.
Cited by
-
Antioxidant Carbon Dots Nanozyme Loaded in Thermosensitive in situ Hydrogel System for Efficient Dry Eye Disease Treatment.Int J Nanomedicine. 2024 May 7;19:4045-4060. doi: 10.2147/IJN.S456613. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38736656 Free PMC article.
-
Dry Eye Disease in the Middle East and Northern Africa: A Position Paper on the Current State and Unmet Needs.Clin Ophthalmol. 2024 Mar 6;18:679-698. doi: 10.2147/OPTH.S436027. eCollection 2024. Clin Ophthalmol. 2024. PMID: 38464499 Free PMC article. Review.
-
Potential applications of artificial intelligence in image analysis in cornea diseases: a review.Eye Vis (Lond). 2024 Mar 7;11(1):10. doi: 10.1186/s40662-024-00376-3. Eye Vis (Lond). 2024. PMID: 38448961 Free PMC article. Review.
-
Overview of CFTR activators and their recent studies for dry eye disease: a review.RSC Med Chem. 2023 Sep 25;14(12):2459-2472. doi: 10.1039/d3md00448a. eCollection 2023 Dec 13. RSC Med Chem. 2023. PMID: 38107177 Review.
-
Understanding CFTR Functionality: A Comprehensive Review of Tests and Modulator Therapy in Cystic Fibrosis.Cell Biochem Biophys. 2024 Mar;82(1):15-34. doi: 10.1007/s12013-023-01200-w. Epub 2023 Dec 4. Cell Biochem Biophys. 2024. PMID: 38048024 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources